A different kind of pharma company

Moberg Pharma

Moberg Pharma is a Swedish specialty pharma company primarily focusing on dermatology products in the OTC segment, with strong market positions in selected niche segments. In addition, Moberg Pharma has two clinical projects. Moberg Pharma has its own sales and marketing organisation in the US and relies on a handful of distribution partners in the other regions. Moberg Pharma has expanded its product offering through a number of acquisitions.

Financials

MOBERG PHARMA

SEKm 2017 2018 2019
Sales 439 415 420
Sales growth (%) 31,3 -5,5 1,3
EBITDA 89 82 84
EBITDA margin (%) 20,4 19,8 20
EBIT adj 51 45 44
EBIT adj margin (%) 11,6 10,9 10,4
Pretax profit 12 6 6
EPS rep 0,61 0,12 0,25
EPS growth (%) -71,8 -81,1 113,9
EPS adj 0,61 0,12 0,25
DPS 0 0 0
EV/EBITDA (x) 11 19,7 19,5
EV/EBIT adj (x) 19,2 35,9 37,4
P/E (x) 45,4 527,3 246,5
P/E adj (x) 45,4 527,3 246,5
EV/sales (x) 2,2 3,9 3,9
FCF yield (%) 7 -0,3 -1,2
Dividend yield (%) 0 0 0
Net IB debt/EBITDA 5,3 6 6